SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. A# 2)*
SEQUUS PHARMACEUTICALS, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK
- --------------------------------------------------------------------------------
(Title of Class of Securities)
817471105
-------------------------------
(CUSIP Number)
Alberto W. Vilar, Amerindo Investment Advisors Inc., One Embarcadero Center,
Suite 2300, San Francisco, CA 94111-3162; Telephone: (415) 362-0292
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Persons
Authorized to Receive Notices and Communications)
April 26, 1996
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D/A, and is filing this
schedule because of Rule 13D-1(b)(3) or (4), check the following space .
---
Check the following space if a fee is being paid with the statement . (A
---
fee is not required only if the reporting person: (1) has a previous statement
on file reporting beneficial ownership of more than five percent of the class
of securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13D-7.)
NOTE: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13D-1(a) for other parties to whom copies are to
be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
(Continued on following page(s))
<PAGE>
817471105
No. CUSIP 13D/A
- --------------------------------------------------------------------------------
1 Name of Reporting Person
SS or IRS Identification No. of Above Person
AMERINDO INVESTMENT ADVISORS INC., a California corporation, AMERINDO
ADVISORS (UK) LIMITED, AMERINDO INVESTMENT ADVISORS, INC., a Panama
corporation, ALBERTO W. VILAR and GARY A. TANAKA, who disaffirm the
existence of any group and who are sometimes collectively referred to as
the "Reporting Persons."
- --------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a group (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Source of funds
00
- --------------------------------------------------------------------------------
5 Check Box if Disclosure of Legal Proceedings is Required [ ]
- --------------------------------------------------------------------------------
6 Citizenship or Place of Organization
See Item 6 of separate cover pages for Reporting Persons
- --------------------------------------------------------------------------------
7 Sole Voting Power
Number of None
Shares -----------------------------------------------------------------
Beneficially 8 Shared Voting Power
Owned By
Each 1,926,786 shares in the aggregate for all Reporting
Reporting Persons and as to all of which beneficial ownership is
Person disclaimed
With -----------------------------------------------------------------
With 9 Sole Dispositive Power
None
-----------------------------------------------------------------
10 Shared Dispositive Power
1,926,786 shares in the aggregate for all Reporting
Persons and as to all of which beneficial ownership is
disclaimed
- --------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned By Each Reporting Person
1,926,786 shares in the aggregate for all Reporting Persons and as to
all of which beneficial ownership is disclaimed
- --------------------------------------------------------------------------------
12 Check Box if the Aggregate Amount in Row (11) excludes Certain
Shares* [X]
- --------------------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
7.59%
- --------------------------------------------------------------------------------
14 Type of Reporting Person*
IA
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
- 2 of 13 -
<PAGE>
817471105
No. CUSIP 13D/A
- --------------------------------------------------------------------------------
1 Name of Reporting Person
SS or IRS Identification No. of Above Person
AMERINDO INVESTMENT ADVISORS INC.
- --------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Source of Funds
00
- --------------------------------------------------------------------------------
5 Check Box if Disclosure of Legal Proceedings is Required [ ]
- --------------------------------------------------------------------------------
6 Citizenship or Place of Organization
California
- --------------------------------------------------------------------------------
7 Sole Voting Power
Number of None
Shares -----------------------------------------------------------------
Beneficially 8 Shared Voting Power
Owned By
Each 627,500 shares, as to all of which beneficial ownership is
Reporting disclaimed
Person -----------------------------------------------------------------
With 9 Sole Dispositive Power
None
-----------------------------------------------------------------
10 Shared Dispositive Power
627,500 shares, as to all of which beneficial ownership is
disclaimed
- --------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned By Each Reporting Person
627,500 shares, as to all of which beneficial ownership is disclaimed
- --------------------------------------------------------------------------------
12 Check Box if the Aggregate Amount in Row (11) excludes Certain
Shares* [X]
- --------------------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
2.47%
- --------------------------------------------------------------------------------
14 Type of Reporting Person*
IA
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
- 3 of 13 -
<PAGE>
817471105
No. CUSIP 13D/A
- --------------------------------------------------------------------------------
1 Name of Reporting Person
SS or IRS Identification No. of Above Person
AMERINDO ADVISORS (UK) LIMITED
- --------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Source of Funds
00
- --------------------------------------------------------------------------------
5 Check Box if Disclosure of Legal Proceedings is Required [ ]
- --------------------------------------------------------------------------------
6 Citizenship or Place of Organization
United Kingdom
- --------------------------------------------------------------------------------
7 Sole Voting Power
Number of None
Shares -----------------------------------------------------------------
Beneficially 8 Shared Voting Power
Owned By
Each None
Reporting
Person -----------------------------------------------------------------
With 9 Sole Dispositive Power
None
-----------------------------------------------------------------
10 Shared Dispositive Power
None
- --------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned By Each Reporting Person
None
- --------------------------------------------------------------------------------
12 Check Box if the Aggregate Amount in Row (11) excludes Certain
Shares* [X]
- --------------------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
0.0%
- --------------------------------------------------------------------------------
14 Type of Reporting Person*
IA
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
- 4 of 13 -
<PAGE>
817471105
No. CUSIP 13D/A
- --------------------------------------------------------------------------------
1 Name of Reporting Person
SS or IRS Identification No. of Above Person
AMERINDO INVESTMENT ADVISORS, INC.
- --------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Source of Funds
00
- --------------------------------------------------------------------------------
5 Check Box if Disclosure of Legal Proceedings is Required [ ]
- --------------------------------------------------------------------------------
6 Citizenship or Place of Organization
Panama
- --------------------------------------------------------------------------------
7 Sole Voting Power
Number of None
Shares -----------------------------------------------------------------
Beneficially 8 Shared Voting Power
Owned By
Each 1,299,286 shares, as to all of which beneficial ownership
Reporting is disclaimed
Person -----------------------------------------------------------------
With 9 Sole Dispositive Power
None
-----------------------------------------------------------------
10 Shared Dispositive Power
1,299,286 shares, as to all of which beneficial ownership
is disclaimed
- --------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned By Each Reporting Person
1,299,286 shares, as to all of which beneficial ownership is disclaimed
- --------------------------------------------------------------------------------
12 Check Box if the Aggregate Amount in Row (11) excludes Certain
Shares* [X]
- --------------------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
5.12%
- --------------------------------------------------------------------------------
14 Type of Reporting Person*
IA
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
- 5 of 13 -
<PAGE>
817471105
No. CUSIP 13D/A
- --------------------------------------------------------------------------------
1 Name of Reporting Person
SS or IRS Identification No. of Above Person
ALBERTO W. VILAR
- --------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Source of Funds
00
- --------------------------------------------------------------------------------
5 Check Box if Disclosure of Legal Proceedings is Required [ ]
- --------------------------------------------------------------------------------
6 Citizenship or Place of Organization
United States
- --------------------------------------------------------------------------------
7 Sole Voting Power
Number of None
Shares -----------------------------------------------------------------
Beneficially 8 Shared Voting Power
Owned By
Each 1,926,786 shares, as to all of which beneficial ownership
Reporting is disclaimed
Person -----------------------------------------------------------------
With 9 Sole Dispositive Power
None
-----------------------------------------------------------------
10 Shared Dispositive Power
1,926,786 shares, as to all of which beneficial ownership
is disclaimed
- --------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned By Each Reporting Person
1,926,786 shares, as to all of which beneficial ownership is disclaimed
- --------------------------------------------------------------------------------
12 Check Box if the Aggregate Amount in Row (11) excludes Certain
Shares* [X]
- --------------------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
7.59%
- --------------------------------------------------------------------------------
14 Type of Reporting Person*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
- 6 of 13 -
<PAGE>
817471105
No. CUSIP 13D/A
- --------------------------------------------------------------------------------
1 Name of Reporting Person
SS or IRS Identification No. of Above Person
GARY A. TANAKA
- --------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Source of Funds
00
- --------------------------------------------------------------------------------
5 Check Box if Disclosure of Legal Proceedings is Required [ ]
- --------------------------------------------------------------------------------
6 Citizenship or Place of Organization
United States
- --------------------------------------------------------------------------------
7 Sole Voting Power
Number of None
Shares -----------------------------------------------------------------
Beneficially 8 Shared Voting Power
Owned By
Each 1,926,786 shares, as to all of which beneficial ownership
Reporting is disclaimed
Person -----------------------------------------------------------------
With 9 Sole Dispositive Power
None
-----------------------------------------------------------------
10 Shared Dispositive Power
1,926,786 shares, as to all of which beneficial ownership
is disclaimed
- --------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned By Each Reporting Person
1,926,786 shares, as to all of which beneficial ownership is disclaimed
- --------------------------------------------------------------------------------
12 Check Box if the Aggregate Amount in Row (11) excludes Certain
Shares* [X]
- --------------------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
7.59%
- --------------------------------------------------------------------------------
14 Type of Reporting Person*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
- 7 of 13 -
<PAGE>
ITEM 1. Security and Issuer.
-------------------
The class of equity securities to which this statement relates is the
Common Stock of Sequus Pharmaceuticals, Inc. ("the Issuer"), whose principal
executive offices are located at 960 Hamilton Court, Menlo Park, CA 94025.
ITEM 2. Identity and Background.
-----------------------
This statement is being filed by Amerindo Investment Advisors Inc., a
California corporation whose principal executive offices are located at One
Embarcadero Center, Suite 2300, San Francisco, California, 94111 ("Amerindo"),
Amerindo Advisors (UK) Limited, a United Kingdom corporation whose principal
executive offices are located at 43 Upper Grosvenor Street, London WIX 9PG
England ("Amerindo UK"), Amerindo Investment Advisors, Inc., a Panama
corporation, whose principal executive offices are located at Edificio Sucre,
Calle 48 Este, Bella Vista, Apartado 6277, Panama 5, Panama ("Amerindo Panama")
and Alberto W. Vilar and Gary A. Tanaka. Although this statement is being made
jointly by Amerindo, Amerindo UK, Amerindo Panama and Messrs. Vilar and Tanaka,
each of them expressly disaffirms membership in any group under Rule 13D-5 under
the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
otherwise.
Amerindo is registered as an investment advisor under the Investment
Advisors Act of 1940, as amended, and Amerindo UK is registered with the
Investment Management Regulatory Organization in the United Kingdom. Messrs.
Alberto W. Vilar and Gary A. Tanaka, whose business addresses are the same as
those set forth for Amerindo and Amerindo UK and each of whom is a U.S. citizen,
are the only directors and executive officers of Amerindo UK and Amerindo
Panama. They are also the only directors and executive officers of Amerindo,
other than Mr. James H. Furey, Chief Operating Officer, and Mr. Joaquin
Garcia-Larrieu, Chief Financial Officer. Mr. Furey's business address is at
Amerindo's offices at 399 Park Avenue, New York, New York 10022, and Mr.
Garcia's business address is Gables International Plaza, 2655 Le Jeune Road,
Suite 1112, Coral Gables, FL 33134. Amerindo, Amerindo UK, Amerindo Panama and
Messrs. Vilar and Tanaka are sometimes hereinafter collectively referred to as
the "Reporting Persons." Messrs. Vilar, Tanaka, Furey and Garcia are sometimes
hereinafter collectively referred to as the "Other Named Individuals."
During the last five years, none of the Reporting Persons or Other
Named Individuals has been convicted in a criminal proceeding (excluding traffic
violations or similar misdemeanors), nor has any such individual or entity been
a party to a civil proceeding of a judicial or administrative body of competent
jurisdiction as a result of which proceeding such individual or entity was or is
subject to a judgment, decree or final order enjoining future violations of, or
prohibiting or mandating activities subject to, Federal or state securities laws
or finding any violation with respect to such laws.
ITEM 3. Source and Amounts of Funds or Other Consideration.
--------------------------------------------------
All purchases of the subject securities by the Reporting Persons have
been in the ordinary course of the respective businesses of Amerindo, Amerindo
UK and Amerindo Panama (collectively, the "Advisor Entities") as investment
advisors. Accordingly, the funds used to purchase the subject securities have
been client funds pertaining to accounts under management. Purchases of the
Issuer's securities by the Named Individuals would all be and have all been made
with their personal funds, except that margin credit may also be, and may have
been, employed.
- 8 of 13 -
<PAGE>
ITEM 4. Purpose of Transaction.
----------------------
All of the subject securities have been purchased by the Advisor
Entities in the ordinary course of their respective businesses as investment
advisors and not with the purpose of effecting changing or influencing the
control of the issuer or in connection with or as a participant in any
transaction having such purpose or effect, including any transaction subject to
Rule 13D-3(b) under the Exchange Act. Additionally, because each of the Advisor
Entities is obligated to act in the best interests of its respective clients and
in accordance with the respective mandates of those clients, there is no
agreement between or among any of the Reporting Persons to act together with
respect to the Issuer or its securities, except that they may, from time to time
and provided that transactions are otherwise being effected at the same time,
aggregate orders for client accounts in order to receive more favorable trading
terms. Any of the subject securities acquired or which might in the future be
acquired by any of the Named Individuals have been and would be acquired for
investment and not with the purpose of effecting of changing or influencing the
control of the issuer or in connection with or as a participant in any
transaction having such purpose or effect, including any transaction subject to
Rule 13D-3(b) under the Exchange Act.
ITEM 5. Interest in Securities of Issuer.
--------------------------------
(a) See Exhibit "A" attached hereto for information setting forth for
each of Reporting Persons and for each Named Individual the aggregate number of
shares of the Common Stock of Issuer beneficially owned by such person as of
April 26, 1996, and the percentage which such shares constitute of the total
number of shares outstanding, as reflected on Issuer's Form 10-K for the Year
ended December 31, 1995, unless information has been obtained as of a later
date directly from the Issuer (with beneficial ownership determined as set forth
in Rule 13D-3 under the Exchange Act, but disclaimed as set forth in the
Exhibit).
(b) Messrs. Vilar and Tanaka share voting and dispositive power over
all shares shown as owned by any of the Reporting Persons; however, each client
of the Advisor Entities has the unilateral right to terminate the advisory
arrangement with the Entity in question on notice which typically need not
exceed 30 days. Each of the Other Named Individuals has sole voting and
dispositive power as to the shares shown in Exhibit "A" as owned by him.
(c) The table contained in Exhibit "B" attached hereto sets forth for
each of the Reporting Persons and Named Individuals information concerning all
acquisitions and dispositions of Issuer's Common Stock by any such person during
the period beginning on February 26, 1996, and ending on April 26, 1996,
including (i) the date of the transaction, (ii) whether the transaction was a
purchase or sale, (iii) the number of shares involved, and (iv) the price per
share at which the transaction was effected. All transactions were effected on
the open market.
(d) The shares covered by this statement are all owned by clients of
the Advisor Entities. No such person's interest in the securities included in
this statement exceeds 5% of the class outstanding.
(e) Inapplicable.
ITEM 6. Contracts, Arrangements, Understandings or
Relationships with Respect to Securities
of the Issuer.
------------------------------------------
Messrs. Vilar and Tanaka are the sole shareholders and directors of
each of the Advisor Entities. As stated above, clients of those Entities
generally have the right to terminate their investment advisory arrangements
with those Entities on notice of 30 days or less.
- 9 of 13 -
<PAGE>
ITEM 7. Material to be Filed as Exhibits.
--------------------------------
Inapplicable.
SIGNATURES
After reasonable inquiry and to the best of our knowledge and belief,
we certify that the information set forth in this statement is true, complete
and correct.
AMERINDO INVESTMENT ADVISORS INC.,
a California corporation
By: /s/ Alberto W. Vilar
------------------------------------
ALBERTO W. VILAR, PRESIDENT
AMERINDO INVESTMENT ADVISORS (UK),
LIMITED, a United Kingdom corporation
By: /s/ Alberto W. Vilar
------------------------------------
ALBERTO W. VILAR, DIRECTOR
AMERINDO INVESTMENT ADVISORS, INC.,
a Panama corporation
By: /s/ Alberto W. Vilar
------------------------------------
ALBERTO W. VILAR, DIRECTOR
By: /s/ Alberto W. Vilar
------------------------------------
ALBERTO W. VILAR
By: /s/ Gary A. Tanaka
------------------------------------
GARY A. TANAKA
- 10 of 13 -
<PAGE>
EXHIBIT A
SEQUUS PHARMACEUTICALS, INC.
COMMON STOCK
817471105
The following table sets forth for each of the Reporting Persons and
for each Other Named Individual the aggregate number of shares of the Common
Stock of the Issuer beneficially owned by such person as of April 26, 1996,
and the percentage which such shares constitute of the total number of shares
outstanding, as reflected on the Issuer's Form 10-K for the Year ended
December 31, 1995, unless based on more recent information obtained directly
from the Issuer (with beneficial ownership determined as set forth in Rule
13D-3 under the Exchange Act, but disclaimed as set forth in the footnote):
NAME NO. OF SHARES(1) PERCENT OF CLASS
- ---- ---------------- ----------------
Amerindo 627,500 2.47%
Amerindo UK 0 0.00%
Amerindo Panama 1,299,286 5.12%
Alberto W. Vilar 1,926,786 7.59%
Gary A. Tanaka 1,926,786 7.59%
James H. Furey 0 0.00%
Joaquin Garcia 0 0.00%
____________________________________
(1) Messrs. Vilar and Tanaka, as the sole directors and shareholders of each of
the Advisor Entities, share voting and investment power as to all shares shown
as owned by the Advisor Entities, but they and the Advisor Entities disclaim
ownership of any of such shares. Each client of the Advisor Entities has the
unilateral right to terminate the advisory arrangement with the Entity in
question on notice which typically need not exceed 30 days.
- 11 of 13 -
<PAGE>
EXHIBIT B
SEQUUS PHARMACEUTICALS, INC.
COMMON STOCK
817471105
The following table sets forth for each of the Reporting Persons and
Other Named Individuals information concerning all acquisitions and dispositions
of the Issuer's Common Stock by any such person during the period beginning on
February 26, 1996, and ending on April 26, 1996, including (i) the date of the
transaction, (ii) whether the transaction was a purchase of sale, (iii) the
number of shares involved, and (iv) the price per share at which the transaction
was effected. All transactions were effected on the open market.
Type of Number Price
Name Date Transaction of Shares per Share
---- ---- ----------- --------- ---------
Amerindo 03/12/96 Sell 10,000 16.625
Amerindo 03/13/96 Sell 10,000 16.375
Amerindo 03/14/96 Sell 45,000 16.167
Amerindo 03/27/96 Sell 10,000 14.125
Amerindo 03/28/96 Sell 20,000 13.875
Amerindo 04/15/96 Sell 25,000 15.500
Amerindo 04/16/96 Sell 10,000 16.125
Amerindo 04/18/96 Sell 47,500 16.474
Amerindo 04/18/96 Sell 15,000 16.375
Amerindo 04/26/96 Sell 12,500 15.375
Amerindo 04/26/96 Sell 12,500 15.000
Amerindo U.K. 03/19/96 Sell 10,000 14.500
Amerindo U.K. 03/21/96 Sell 25,000 14.325
Amerindo U.K 03/22/96 Sell 40,000 14.125
Amerindo Panama 03/28/96 Sell 15,000 13.875
- 12 of 13 -
<PAGE>
EXHIBIT C
SEQUUS PHARMACEUTICALS, INC.
COMMON STOCK
817471105
We hereby agree that the within Statement on Schedule 13D/A regarding our
beneficial ownership of Common Stock is filed on behalf of each of us.
AMERINDO INVESTMENT ADVISORS INC.,
a California corporation
By: /s/ Alberto W. Vilar
------------------------------------
ALBERTO W. VILAR, PRESIDENT
AMERINDO INVESTMENT ADVISORS (UK),
LIMITED, a United Kingdom corporation
By: /s/ Alberto W. Vilar
------------------------------------
ALBERTO W. VILAR, DIRECTOR
AMERINDO INVESTMENT ADVISORS, INC.,
a Panama corporation
By: /s/ Alberto W. Vilar
------------------------------------
ALBERTO W. VILAR, DIRECTOR
By: /s/ Alberto W. Vilar
------------------------------------
ALBERTO W. VILAR
By: /s/ Gary A. Tanaka
------------------------------------
GARY A. TANAKA
- 13 of 13 -
